[go: up one dir, main page]

PE20090619A1 - USO DE ANTAGONISTAS DE mGluR5 PARA EL TRATAMIENTO DE LA GERD - Google Patents

USO DE ANTAGONISTAS DE mGluR5 PARA EL TRATAMIENTO DE LA GERD

Info

Publication number
PE20090619A1
PE20090619A1 PE2008001400A PE2008001400A PE20090619A1 PE 20090619 A1 PE20090619 A1 PE 20090619A1 PE 2008001400 A PE2008001400 A PE 2008001400A PE 2008001400 A PE2008001400 A PE 2008001400A PE 20090619 A1 PE20090619 A1 PE 20090619A1
Authority
PE
Peru
Prior art keywords
phenyl
fluor
alkyl
gerd
pyridine
Prior art date
Application number
PE2008001400A
Other languages
English (en)
Inventor
Georg Jaeschke
Sabine Kolczewski
Will Spooren
Eric Vieira
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20090619A1 publication Critical patent/PE20090619A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIRIDINA DE FORMULA (I) DONDE A O E ES N Y EL OTRO ES C; R1 ES HALOGENO; R2 ES ALQUILO(C1-C6); R3 ES FENILO, PIRIMIDINILO, PIRAZINILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON HALOGENO, ALQUILO(C1-C6), ALCOXI(C1-C6), ENTRE OTROS SUSTITUYENTES; R4 ES CHF2, CF3, CH2OH O ALQUILO(C1-C6). SON COMPUESTOS PREFERIDOS: 2-CLORO-4-[1-(4-FLUOR-FENIL)-2,5-DIMETIL-1H-IMIDAZOL-4-IL-ETINIL]-PIRIDINA, 2-CLORO-4-[5-DIFLUORMETIL-1-(4-FLUOR-FENIL)-2-METIL-1H-IMIDAZOL-4-ILETINIL]-PIRIDINA, [5-(2-CLORO-PIRIDIN-4-ILETINIL)-3-(4-FLUOR-FENIL)-2-METIL-3H-IMIDAZOL-4-IL]-METANOL, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DE LOS RECEPTORES METABOTROPICOS DE GLUTAMATO DE TIPO 5 (mGluR5) SIENDO UTILES EN EL TRATAMIENTO DE LA ENFERMEDAD DEL REFLUJO GASTRO-ESOFAGICO (GERD)
PE2008001400A 2007-08-20 2008-08-18 USO DE ANTAGONISTAS DE mGluR5 PARA EL TRATAMIENTO DE LA GERD PE20090619A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07114582 2007-08-20

Publications (1)

Publication Number Publication Date
PE20090619A1 true PE20090619A1 (es) 2009-05-16

Family

ID=40040052

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001400A PE20090619A1 (es) 2007-08-20 2008-08-18 USO DE ANTAGONISTAS DE mGluR5 PARA EL TRATAMIENTO DE LA GERD

Country Status (6)

Country Link
US (1) US20090054490A1 (es)
AR (1) AR070020A1 (es)
CL (1) CL2008002440A1 (es)
PE (1) PE20090619A1 (es)
TW (1) TW200924764A (es)
WO (1) WO2009024491A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642626B2 (en) 2010-07-29 2014-02-04 Taisho Pharmaceutical Co., Ltd. Ethinyl-pyrazole derivative
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20130274294A1 (en) * 2010-12-20 2013-10-17 David Carcache 4-(Hetero)Aryl-Ethynyl-Octahydro-Indole-1-Esters
WO2020163689A1 (en) 2019-02-08 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201943D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New use
ATE495168T1 (de) * 2003-06-12 2011-01-15 Hoffmann La Roche Heteroarylsubstituierte imidazolderivate als glutamatrezeptorantagonisten
CN1960984B (zh) * 2004-06-01 2010-05-12 弗·哈夫曼-拉罗切有限公司 作为mglu5受体拮抗剂的吡啶-4-基-乙炔基-咪唑和吡唑
GB0514296D0 (en) * 2005-07-12 2005-08-17 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20090054490A1 (en) 2009-02-26
TW200924764A (en) 2009-06-16
AR070020A1 (es) 2010-03-10
WO2009024491A1 (en) 2009-02-26
CL2008002440A1 (es) 2009-07-31

Similar Documents

Publication Publication Date Title
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
CY1108744T1 (el) 2-οξο-1,2,4,5-τετραϋδρo-1,3-βενζοδιαζεπιν-3-υλ-πιπεριδινες ως ανταγωνιστες της cgrp
EA200901379A1 (ru) Производные никотиновой кислоты как модуляторы метаботропных глутаматных рецепторов 5 подтипа
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
PE20091204A1 (es) Derivados de 2-aminoquinolina como antagonistas del receptor de 5-ht5a
PE20090875A1 (es) Derivados de tetrazol como moduladores de los receptores de glutamato metabotropicos
PE20100087A1 (es) Compuestos y composiciones como inhibidores de cinasa
PE20142301A1 (es) Uracilos sustituidos biciclicamente y uso de los mismos
PE20081447A1 (es) Compuestos y composiciones como inhibidores de la proteina cinasa
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20091243A1 (es) Compuesto heterociclico fusionado
PE20061436A1 (es) Derivados de amida sustituida como inhibidores de proteina quinasa
PE20130242A1 (es) Derivados de isoxazolo-piridina
PE20080065A1 (es) Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1
PE20090949A1 (es) Compuesto heterociclico y composicion farmaceutica del mismo
NO20074287L (no) Pyrazin-2-karboksamidderivater som mGluR5 antagonister
PE20110028A1 (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato
PE20060079A1 (es) DERIVADOS DE PIRIDILO COMO ANTAGONISTAS DEL RECEPTOR mGlus5
PE20081735A1 (es) Derivados de 1-oxa-3[4,5]decan-2-ona en el tratamiento de trastornos alimenticios
PE20091450A1 (es) INHIBIDORES DE LA ESTEAROIL-CoA-DESATURASA
PE20060589A1 (es) FENILAMINOTIAZOLES SUSTITUIDOS COMO AGONISTAS DE ADENOSINA A1 Y A2b
PE20061163A1 (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion
PE20061144A1 (es) DERIVADOS DE PIRROLIDINA Y PIPERIDINA ACETILENO COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO METABOTROPICO (mGluRs)
PE20090619A1 (es) USO DE ANTAGONISTAS DE mGluR5 PARA EL TRATAMIENTO DE LA GERD

Legal Events

Date Code Title Description
FA Abandonment or withdrawal